Galecto Inc
NASDAQ:GLTO
Galecto Inc
Accounts Receivables
Galecto Inc
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Galecto Inc
NASDAQ:GLTO
|
Accounts Receivables
$1m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Accounts Receivables
kr4.7B
|
CAGR 3-Years
36%
|
CAGR 5-Years
46%
|
CAGR 10-Years
36%
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Accounts Receivables
kr139.4m
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Accounts Receivables
€41.1m
|
CAGR 3-Years
643%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Accounts Receivables
kr674.9m
|
CAGR 3-Years
60%
|
CAGR 5-Years
85%
|
CAGR 10-Years
18%
|
Bioporto A/S
CSE:BIOPOR
|
Accounts Receivables
kr4.7m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
See Also
What is Galecto Inc's Accounts Receivables?
Accounts Receivables
1m
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's Accounts Receivables amounts to 1m USD.
What is Galecto Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
-19%
Over the last year, the Accounts Receivables growth was -30%. The average annual Accounts Receivables growth rates for Galecto Inc have been -13% over the past three years , -19% over the past five years .